Clinical trial
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent…
NCT00276770 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00276770 |
|---|---|
| Title | Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas |
| Official title | NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy Using [F18] Fluorothymidine (FLT) As a Marker of Proliferation in Patients With Primary Brain Tumors |
| Lead sponsor | University of Washington, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Other, Procedure |
| Interventions | fluorine F 18 fluorothymidine, positron emission tomography |
| Enrollment | 12 |
| Start date | Feb 1, 2006 |
| Primary completion | May 1, 2007 |
| First posted | Jan 13, 2006 |
| Last update posted | Feb 27, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: